TrialJournal of neuro-oncology2014
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).
Marc C Chamberlain et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papertrialcites it